Even though Cathay General Bancorp (currently trading at $48.37 per share) has gained 10.6% over the last six months, it has ...

Rocket Lab posted strong Q2 growth with rising margins, a $1B backlog, and solid liquidity to support Neutron and NSSL ...

Members of Girl Scout Troop 01150 celebrate the new garden they planted at Amity Community Church in Greenfield. The girls inspected and hand-washed tens of thousands of caps, which they had made into ...

Small-cap stocks are regaining investor attention after a prolonged period of underperformance relative to their large-cap counterparts, especially the mega-cap tech giants that have lately driven ...

While large-cap megatech stocks have dominated the investment landscape in recent years, there’s one hedge fund specializing in small-caps whose performance has been outstripping most of them this ...

The Russell 2000 has returned 7% so far in 2025 but performance has been improving of late and the Fed's easing cycle is expected to improve prospects for the asset class. While large-cap megatech ...

President Donald Trump wrapped up the week Friday by signing an executive order to change the name of the Department of Defense to the Department of War. The executive order gives the green light to ...

In this article, we will look at the 10 Best Small Cap Tech Stocks to Buy Right Now. On August 29, Craig Johnson, Chief Market Technician at Piper Sandler, joined CNBC Television to discuss his bull ...

IWM also surged almost 4% on Aug. 22, one of its best single-day performances for the year. Small-cap ETFs such as IWM are most sensitive to interest rates because declining borrowing costs can ...

The Army has cut a program it used in recent years to pick officers to lead battalions and brigades and select to the top enlisted leaders for those formations, the service’s Human Resources Command ...

In the afternoon, a veteran ICE official, Matt Elliston, took the stage to answer questions. There were queries about ...

Pulmonary sarcoidosis patients could soon get the treatment option they've been waiting for from aTyr Pharma. MoonLake Immunotherapeutics is running multiple phase 3 programs for its lead candidate.